Author:
Nagy Nadine,Kaber Gernot,Haddock Naomi L.,Hargil Aviv,Rajadas Jayakumar,Malhotra Sanjay V.,Unger Marc A.,Frymoyer Adam R.,Bollyky Paul L.
Publisher
Springer International Publishing
Reference32 articles.
1. Abate A, Dimartino V, Spina P, Costa PL, Lombardo C, Santini A, Del Piano M, Alimonti P (2001) Hymecromone in the treatment of motor disorders of the bile ducts: a multicenter, double-blind, placebo-controlled clinical study. Drugs Exp Clin Res 27:223–231
2. Bollyky PL, Bogdani M, Bollyky JB, Hull RL, Wight TN (2012) The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep 12:471–480
3. Bollyky PL, Evanko SP, Wu RP, Potter-Perigo S, Long SA, Kinsella B, Reijonen H, Guebtner K, Teng B, Chan CK, Braun KR, Gebe JA, Nepom GT, Wight TN (2010) Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan pro-duction and accumulation at the immune synapse. Cell Mol Immunol 7:211–220
4. Camarri E, Marchettini G (1988) Hymecromone in the treatment of symptoms following surgery of the bile ducts. Recenti Prog Med 79:198–202
5. Cheng G, Swaidani S, Sharma M, Lauer ME, Hascall VC, Aronica MA (2011) Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthma. Matrix Biol 30., Cross Ref Medline:126–134